A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
Jesse J. Swen(Leiden University Medical Center), Roelof Bosch, Rudolf Koopmann(MBN Research Center), C. Fajardo(Instituto de Investigación Biosanitaria de Granada), Lisanne E. N. Manson(Leiden University), Magnus Ingelman‐Sundberg(Karolinska Institutet), Vera H.M. Deneer(Utrecht University), Μαρία Σκώκου(University of Patras), H. Abdullah-Koolmees(University Medical Center Utrecht), Anne‐Marie Buunk, Victoria Rollinson(University of Liverpool), Christina Mitropoulou(United Arab Emirates University), George P. Patrinos(University of Patras), Henk‐Jan Guchelaar(Leiden University Medical Center), Tanja Blagus(University of Ljubljana), Mathilde Dupui(Pharmacochimie et Biologie pour le Développement), Cathelijne H. van der Wouden(Leiden University), Gere Sunder–Plassmann(Medical University of Vienna), Emmanuelle Rial‐Sebbag(Université Fédérale de Toulouse Midi-Pyrénées), Marjolein Kriek(Leiden University), Kathrin Blagec(Austrian Research Institute for Artificial Intelligence), Lidija Konta, Sara Musaafir, Anne Cambon‐Thomsen(Université Toulouse III - Paul Sabatier), Thijs Ambagts, Matthias Schwab(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Rossana Roncato(Centro di Riferimento Oncologico), Katja S. Just(RWTH Aachen University), Elke Schaeffeler(German Cancer Research Center), Erika Cecchin(Centro di Riferimento Oncologico), Gert Baas, Giuseppe Toffoli(Centro di Riferimento Oncologico), Vita Dolžan, Mats O. Karlsson(Uppsala University), Roman Tremmel(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Evelyn Schuil-Vlassak, Candace Joefield‐Roka(Medical University of Vienna), Julia Stingl(RWTH Aachen University), Thorsten Lehr(Saarland University), Richard M. Turner(University of Liverpool), Matthias Samwald(Konrad Lorenz Institute for Evolution and Cognition Research), Hanneke Goossens, Stefan Böhringer(Leiden University), Maartje Algera, Leonie De Hoog-Schouten, Mandy H. van Rhenen(Royal Dutch Pharmacists Association), Daniela Steinberger(MBN Research Center), Munir Pirmohamed(University of Liverpool), Ka‐Chun Cheung(Royal Dutch Pharmacists Association), Siv Jönsson(Uppsala University)
Cited by 508
Related Papers
A roadmap for graphene
|Nature|2012|9.1k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
|Journal of the American College of Cardiology|2013|826